|

Early Treatment of Atrial Fibrillation for Stroke Prevention Trial in Acute STROKE

RECRUITINGPhase 3Sponsored by Universitätsklinikum Hamburg-Eppendorf
Actively Recruiting
PhasePhase 3
SponsorUniversitätsklinikum Hamburg-Eppendorf
Started2025-11-06
Est. completion2031-07
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT05293080

Summary

This study will determine whether early, comprehensive, rhythm control therapy prevents adverse cardiovascular outcome in patients with acute ischemic stroke and atrial fibrillation compared to usual care.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Acute ischemic stroke in the previous four weeks, diagnosed by imaging (CT or MRI) or clinical diagnosis
* Possibility to start the trial treatment within 4 weeks after stroke, and as soon as clinically justifiable
* AF first detected ≤1 year prior to randomization
* Informed consent

Exclusion Criteria:

* End-stage cancer or life-expectancy \< 12 months due to other advanced co-morbid illness
* Prior AF ablation or surgical therapy of AF
* Patients not suitable for rhythm control of AF due to cardiac conditions

Conditions3

Acute Ischemic StrokeAtrial FibrillationHeart Disease

Browse More Trials

Heart Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.